ANGIOX

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug ANGIOX contains one active pharmaceutical ingredient (API):

1 Bivalirudin
UNII TN9BEX005G - BIVALIRUDIN

Bivalirudin is a direct and specific thrombin inhibitor that binds both to the catalytic site and the anion-binding exosite of fluid-phase and clot-bound thrombin.

Read about Bivalirudin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
Angiox 250mg powder for concentrate for solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B01AE06 Bivalirudin B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1167601
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1027375

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈